Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, representing a minor page/system update without changes to the study information displayed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded access to study documents (protocol and SAP) and related metadata on the study details page, while removing an error page placeholder. This provides a more complete view of the trial documentation and topics.SummaryDifference50%

- Check25 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor backend update to the study page.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study details or participant-facing content appear to be altered.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small page/document update rather than a change to study details.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision label was updated to v3.6.2. It replaces the previous v3.6.0 revision.SummaryDifference0.1%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.